Instillagel

Chlorhexidine gluconate, the active ingredient in Instillagel, is an antiseptic and local anesthetic presented as a gel for urethral use. It is combined with lidocaine hydrochloride and preservative agents to provide antimicrobial protection and temporary numbing during procedures such as catheter insertion.

GNH USA supplies Instillagel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Customers benefit from reliable supply chains and responsive technical support.

Instillagel is used as a urogenital antiseptic to reduce microbial contamination during urethral procedures. - Urethral antisepsis: reduces bacterial load in the urethra prior to instrumentation. - Catheterization: helps prevent urinary tract infection associated with catheter insertion. - Surgical preparation: provides local anesthesia and antisepsis during minor urological surgeries.

Instillagel may cause local and systemic adverse reactions.

Common Side Effects: - Mild urethral irritation: transient burning or stinging sensation. - Localized discomfort: brief dysuria or feeling of fullness. - Minor allergic reaction: redness or mild swelling at the application site.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic response requiring immediate medical attention. - Urethral ulceration: deep tissue injury or necrosis. - Systemic lidocaine toxicity: symptoms such as dizziness, tinnitus, or cardiac arrhythmia.

Use of Instillagel requires careful consideration of patient safety. - Allergy assessment: verify no known hypersensitivity to chlorhexidine or lidocaine. - Infection status: avoid in active urethral infections unless directed by a clinician. - Application volume: apply only the prescribed amount to prevent excess exposure. - Systemic monitoring: watch for signs of lidocaine toxicity, especially in prolonged use. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk. - Store at room temperature: keep in the original container, protect from light and moisture.

Instillagel can interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concurrent local anesthetics: may increase systemic lidocaine levels. - Systemic chlorhexidine preparations: risk of additive toxicity. - QT‑prolonging drugs: lidocaine may exacerbate cardiac conduction effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may alter lidocaine metabolism. - Antifungal agents: potential additive mucosal irritation. - Renal impairment: monitor for accumulation of lidocaine. - Hepatic dysfunction: may affect clearance of lidocaine.